Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Machet

Showing results (261-270 of 377) with videos related to

Pageof 38
Sort By:
International Journal of Cancer|September 28, 2002
The kinetics of the visible growth of a primary melanoma reflects the tumor aggressiveness and is an independent prognostic marker: a prospective studyJean Jacques Grob, Marie Aleth Richard, Johany Gouvernet, et al.
Neuro-Oncology|March 18, 2016
Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signalingDominique Figarella-Branger, Emmanuèle Lechapt-Zalcman, Emeline Tabouret, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 28, 2023
Efficacy of imiquimod in the management of lentigo malignaMarie Daude, Monica Dinulescu, Jean-Michel Nguyen, et al.
International Journal of Cancer|June 22, 2000
Delays in diagnosis and melanoma prognosis (II): the role of doctorsM A Richard, J J Grob, M F Avril, et al.
Archives of Dermatology|March 23, 1999
Melanoma and tumor thickness: challenges of early diagnosisM A Richard, J J Grob, M F Avril, et al.
American Journal of Clinical Pathology|June 29, 2005
Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a reviewTony Petrella, Martine Bagot, Rein Willemze, et al.
International Journal of Cancer|June 22, 2000
Delays in diagnosis and melanoma prognosis (I): the role of patientsM A Richard, J J Grob, M F Avril, et al.
Cancer|July 4, 2025
Administration of nivolumab plus ipilimumab: Infusion of the fixed-ratio combination versus sequential infusions in two randomized controlled trials of metastatic melanoma (CheckMate 742) and renal cell carcinoma (CheckMate 800)Alexander M Menzies, Pamela Salman, Osvaldo Arén Frontera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2011
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized studyT Jouary, C Leyral, B Dreno, et al.
Rheumatology (Oxford, England)|January 11, 2026
The immune cell landscape analyzed by imaging mass cytometry in the muscle of patients with inclusion body myositis associated or not with Sjögren's diseaseBaptiste Quéré, Amélie Bourhis, Patrice Hemon, et al.
Pageof 38

Showing results (261-270 of 377) with videos related to

Sort By:
Pageof 38
International Journal of Cancer|September 28, 2002
The kinetics of the visible growth of a primary melanoma reflects the tumor aggressiveness and is an independent prognostic marker: a prospective studyJean Jacques Grob, Marie Aleth Richard, Johany Gouvernet, et al.
Neuro-Oncology|March 18, 2016
Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signalingDominique Figarella-Branger, Emmanuèle Lechapt-Zalcman, Emeline Tabouret, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 28, 2023
Efficacy of imiquimod in the management of lentigo malignaMarie Daude, Monica Dinulescu, Jean-Michel Nguyen, et al.
International Journal of Cancer|June 22, 2000
Delays in diagnosis and melanoma prognosis (II): the role of doctorsM A Richard, J J Grob, M F Avril, et al.
Archives of Dermatology|March 23, 1999
Melanoma and tumor thickness: challenges of early diagnosisM A Richard, J J Grob, M F Avril, et al.
American Journal of Clinical Pathology|June 29, 2005
Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a reviewTony Petrella, Martine Bagot, Rein Willemze, et al.
International Journal of Cancer|June 22, 2000
Delays in diagnosis and melanoma prognosis (I): the role of patientsM A Richard, J J Grob, M F Avril, et al.
Cancer|July 4, 2025
Administration of nivolumab plus ipilimumab: Infusion of the fixed-ratio combination versus sequential infusions in two randomized controlled trials of metastatic melanoma (CheckMate 742) and renal cell carcinoma (CheckMate 800)Alexander M Menzies, Pamela Salman, Osvaldo Arén Frontera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2011
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized studyT Jouary, C Leyral, B Dreno, et al.
Rheumatology (Oxford, England)|January 11, 2026
The immune cell landscape analyzed by imaging mass cytometry in the muscle of patients with inclusion body myositis associated or not with Sjögren's diseaseBaptiste Quéré, Amélie Bourhis, Patrice Hemon, et al.
Pageof 38